Paper24533232
Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease.
Ngu SF and 1 other. Curr Obstet Gynecol Rep, 2014. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease. Papers, record 24533232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24533232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19345988 | Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia. | Gynecol Oncol | 2009 | https://conductscience.org/library/papers/19345988 | PubMed |
| 2 | 20660042 | Hyperglycosylated hCG is a marker of early human trophoblast invasion. | J Clin Endocrinol Metab | 2010 | https://conductscience.org/library/papers/20660042 | PubMed |
| 3 | 17711444 | EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients. | Int J Gynecol Cancer | 2008 | https://conductscience.org/library/papers/17711444 | PubMed |
| 4 | 15283048 | Inappropriate management of women with persistent low hCG results. | J Reprod Med | 2004 | https://conductscience.org/library/papers/15283048 | PubMed |
| 5 | 19822356 | Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases. | Gynecol Oncol | 2010 | https://conductscience.org/library/papers/19822356 | PubMed |
| 6 | 15008778 | Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgery. | BJOG | 2004 | https://conductscience.org/library/papers/15008778 | PubMed |
| 7 | 16631243 | Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results. | Gynecol Oncol | 2006 | https://conductscience.org/library/papers/16631243 | PubMed |
| 8 | 22130490 | Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study. | Lancet | 2012 | https://conductscience.org/library/papers/22130490 | PubMed |
| 9 | 20619452 | Hyperglycosylated hCG, a review. | Placenta | 2010 | https://conductscience.org/library/papers/20619452 | PubMed |
| 10 | 22455390 | hCG, the wonder of today's science. | Reprod Biol Endocrinol | 2012 | https://conductscience.org/library/papers/22455390 | PubMed |
| 11 | 18708429 | Gestational trophoblastic disease: current management of hydatidiform mole. | BMJ | 2008 | https://conductscience.org/library/papers/18708429 | PubMed |
| 12 | 17481633 | Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen. | Int J Gynaecol Obstet | 2007 | https://conductscience.org/library/papers/17481633 | PubMed |
| 13 | 12209690 | Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors. | Cancer | 2002 | https://conductscience.org/library/papers/12209690 | PubMed |
| 14 | 19301571 | Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China. | J Reprod Med | 2009 | https://conductscience.org/library/papers/19301571 | PubMed |
| 15 | 22449733 | Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy. | Gynecol Oncol | 2012 | https://conductscience.org/library/papers/22449733 | PubMed |
| 16 | 17977170 | Efficacy of the FAEV regimen in the treatment of high-risk, drug-resistant gestational trophoblastic tumor. | J Reprod Med | 2007 | https://conductscience.org/library/papers/17977170 | PubMed |
| 17 | 11925147 | Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a case report. | Gynecol Oncol | 2002 | https://conductscience.org/library/papers/11925147 | PubMed |
| 18 | 11919242 | Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. | J Clin Oncol | 2002 | https://conductscience.org/library/papers/11919242 | PubMed |
| 19 | 21239399 | Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia. | Ann Oncol | 2011 | https://conductscience.org/library/papers/21239399 | PubMed |
| 20 | 12477450 | Role of hysterectomy in management of gestational trophoblastic disease. | Gynecol Oncol | 2002 | https://conductscience.org/library/papers/12477450 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42588652 | Persistent Low-Level hCG After Gestational Trophoblastic Neoplasia Remission: Treatment-Free Probability Stratified by Early hCG Course. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588652 | PubMed |
| 36936581 | Advances in the diagnosis and early management of gestational trophoblastic disease. | BMJ Med | 2022 | https://conductscience.org/library/papers/36936581 | PubMed |
| 34127641 | A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation. | Am J Case Rep | 2021 | https://conductscience.org/library/papers/34127641 | PubMed |
| 33446242 | Hyperthyroidism in gestational trophoblastic disease - a literature review. | Thyroid Res | 2021 | https://conductscience.org/library/papers/33446242 | PubMed |
| 32509606 | A review on management of gestational trophoblastic neoplasia. | J Family Med Prim Care | 2020 | https://conductscience.org/library/papers/32509606 | PubMed |
| 32483804 | Evaluation of High-Dose Vitamin A Treatment in Postmolar Patients with Low and Plateauing Serum Human Chorionic Gonadotropin Levels. | Rev Bras Ginecol Obstet | 2020 | https://conductscience.org/library/papers/32483804 | PubMed |
| 31897223 | CD105 overexpression mediates drug-resistance in choriocarcinoma cells through BMP9/Smad pathway. | J Cancer | 2020 | https://conductscience.org/library/papers/31897223 | PubMed |
| 31489099 | Gestational trophoblastic neoplasia: experience at Salah Azaiez Institute. | Pan Afr Med J | 2019 | https://conductscience.org/library/papers/31489099 | PubMed |
| 31337386 | Spontaneous regression of quiescent gestational trophoblastic disease after pregnancy: a case report. | BMC Womens Health | 2019 | https://conductscience.org/library/papers/31337386 | PubMed |
| 31219560 | BRCA1 promoter hypermethylation in human placenta: a hidden link with β-hCG expression. | Carcinogenesis | 2020 | https://conductscience.org/library/papers/31219560 | PubMed |
| 29367697 | Identification of microRNA signature in the progression of gestational trophoblastic disease. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29367697 | PubMed |
| 28653031 | The "hook effect" causing a negative pregnancy test in a patient with an advanced molar pregnancy. | Gynecol Oncol Rep | 2017 | https://conductscience.org/library/papers/28653031 | PubMed |
| 28116190 | Incidental Finding of Persistent Hydatidiform Mole in an Adolescent on Depo-Provera. | Case Rep Obstet Gynecol | 2016 | https://conductscience.org/library/papers/28116190 | PubMed |
| 27899973 | Expression patterns of maspin and mutant p53 are associated with the development of gestational trophoblastic neoplasia. | Oncol Lett | 2016 | https://conductscience.org/library/papers/27899973 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CGB5 | 93659 | PubTator's text mining | https://conductscience.org/library/genes/93659 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24533232
GET https://conductscience.org/api/papers/v1/24533232/references?page=2